DEERFIELD PARTNERS, L.P.

CIK 000130104111 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001301041

Recent Transactions

50 trades

Purchase
Nuvalent, Inc.$NUVL
Class A Common Stock
2022-11-03$33.50/sh+650,000→ 650,000 total
Purchase
Nuvalent, Inc.$NUVL
Class A Common Stock
2022-11-03$33.50/sh+650,000→ 650,000 total
Purchase
Xilio Therapeutics, Inc.$XLO
Common Stock
2021-10-26$16.00/sh+387,500→ 1,143,972 total
Conversion
Xilio Therapeutics, Inc.$XLO
Common Stock
2021-10-26+756,472→ 756,472 total
Purchase
Xilio Therapeutics, Inc.$XLO
Common Stock
2021-10-26$16.00/sh+387,500→ 1,143,972 total
Conversion
Xilio Therapeutics, Inc.$XLO
Series C Preferred Stock
2021-10-26−7,186,489→ 0 total
Purchase
Xilio Therapeutics, Inc.$XLO
Common Stock
2021-10-26$16.00/sh+387,500→ 1,143,972 total
Conversion
Xilio Therapeutics, Inc.$XLO
Common Stock
2021-10-26+756,472→ 756,472 total
Conversion
Xilio Therapeutics, Inc.$XLO
Common Stock
2021-10-26+756,472→ 756,472 total
Purchase
Xilio Therapeutics, Inc.$XLO
Common Stock
2021-10-26$16.00/sh+387,500→ 1,143,972 total
Conversion
Xilio Therapeutics, Inc.$XLO
Series C Preferred Stock
2021-10-26−7,186,489→ 0 total
Conversion
Xilio Therapeutics, Inc.$XLO
Common Stock
2021-10-26+756,472→ 756,472 total
Conversion
Xilio Therapeutics, Inc.$XLO
Series C Preferred Stock
2021-10-26−7,186,489→ 0 total
Conversion
Xilio Therapeutics, Inc.$XLO
Series C Preferred Stock
2021-10-26−7,186,489→ 0 total
Other
Aclaris Therapeutics, Inc.$ACRS
Cash-Settled Total Return Swap
2018-12-28+1→ 1 total
Other
Aclaris Therapeutics, Inc.$ACRS
Cash-Settled Total Return Swap
2018-12-28+1→ 1 total
Other
Aclaris Therapeutics, Inc.$ACRS
Cash-Settled Total Return Swap
2018-12-28+1→ 1 total
Other
Aclaris Therapeutics, Inc.$ACRS
Cash-Settled Total Return Swap
2018-12-28+1→ 1 total
Other
Aclaris Therapeutics, Inc.$ACRS
Cash-Settled Total Return Swap
2018-12-28+1→ 1 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−34,349→ 975,375 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−34,349→ 975,375 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−34,349→ 975,375 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−87,886→ 494,718 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−87,886→ 494,718 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−27,765→ 788,415 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−27,765→ 788,415 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−27,765→ 788,415 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−87,886→ 494,718 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−87,886→ 494,718 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−87,886→ 494,718 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−34,349→ 975,375 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−34,349→ 975,375 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−27,765→ 788,415 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−87,886→ 494,718 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−27,765→ 788,415 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−27,765→ 788,415 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−34,349→ 975,375 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−34,349→ 975,375 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−27,765→ 788,415 total
Sale
eHealth, Inc.$EHTH
Common Stock
2017-04-13$11.00/sh−87,886→ 494,718 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2016-09-19$15.53/sh−3,857→ 1,992,798 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2016-09-19$15.58/sh−37,044→ 919,718 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2016-09-19$15.53/sh−3,857→ 1,992,798 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2016-09-19$15.53/sh−4,910→ 2,536,289 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2016-09-19$15.58/sh−37,044→ 919,718 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2016-09-19$15.58/sh−37,044→ 919,718 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2016-09-19$15.53/sh−4,910→ 2,536,289 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2016-09-19$15.53/sh−4,910→ 2,536,289 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2016-09-19$15.53/sh−4,910→ 2,536,289 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2016-09-19$15.58/sh−37,044→ 919,718 total

Companies

Recent Filings

4
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Sep 17, 2024

Address

345 PARK AVENUE SOUTH, 12TH FLOOR

NEW YORK, NY, 10010

View on SEC.gov